A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang, Namir Shaabani, Kaustav Khatua, R. Xinyu, Erol C. Vatansever, Chia-Chuan Cho, Yuying Ma, Jing Xiao, Lauren R. Blankenship, Ge Yu, Banumathi Sankaran, Pingwei Li, Robert D. Allen, Henry Ji, Shiqing Xu, Wenshe Ray Liu
Topics & Concepts
BoceprevirChemistryVirologyProteaseTelaprevirSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)EnzymeBiochemistryRibavirinMedicineInfectious disease (medical specialty)GenePathologyDiseaseGenotypeComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies